TENX INVESTOR ALERT: Tenax Therapeutics, Inc. Investors with Substantial Losses May Seek to Lead Class Action Lawsuit Before December 28, 2026 Deadline
SAN DIEGO, Nov. 1, 2026 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Tenax Therapeutics, Inc. (NASDAQ: TENX) securities between November 13, 2023 and August 7, 2026, both dates inclusive (the "Class Period"), have until...
Covered in this story
Call it yourself
No calls on $TENX yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Tenax Therapeutics →Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.